Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Encompass Health ( (EHC) ) has shared an update.
At the Annual Meeting held on May 7, 2026, Encompass Health stockholders voted on the election of ten board nominees, ratification of PricewaterhouseCoopers LLP as independent auditor, and approval of executive compensation, with 92.5% of the company’s 99,565,304 outstanding shares represented by proxy. All ten director nominees were elected with strong support, reinforcing the company’s existing governance structure and signaling continued stockholder confidence in its leadership and oversight framework.
These voting outcomes consolidate the current board’s strategic direction and maintain continuity in financial oversight through the reappointment of PricewaterhouseCoopers LLP, which may support stability in reporting and investor relations. Approval of named executive officer compensation also indicates investor backing for the company’s pay practices, potentially easing governance pressures and aligning management incentives with stockholder expectations.
The most recent analyst rating on (EHC) stock is a Buy with a $140.00 price target. To see the full list of analyst forecasts on Encompass Health stock, see the EHC Stock Forecast page.
Spark’s Take on EHC Stock
According to Spark, TipRanks’ AI Analyst, EHC is a Outperform.
The score is driven primarily by solid underlying financial performance (steady growth, good profitability, improving leverage) and a notably positive earnings call with raised 2026 guidance and strong operational metrics. These strengths are partly offset by weak current technicals (below key moving averages with negative MACD) and only moderate valuation support given the modest dividend yield.
To see Spark’s full report on EHC stock, click here.
More about Encompass Health
Encompass Health Corporation operates in the healthcare sector, focusing on inpatient rehabilitation hospitals and related post-acute services for patients recovering from major illnesses, injuries, or surgeries. The company targets U.S. healthcare markets where demand for rehabilitation and comprehensive recovery care is growing, positioning itself as a key provider in the post-acute continuum.
Average Trading Volume: 1,018,338
Technical Sentiment Signal: Buy
Current Market Cap: $10.53B
For an in-depth examination of EHC stock, go to TipRanks’ Overview page.